NewsBenzinga美国食品和药物管理局于2026年9月25日批准Juvmo(Tavapadon)用于成人帕金森病 美国食品和药物管理局于2026年9月25日批准Juvmo(Tavapadon)用于成人帕金森病 Benzinga 2026.09.25 22:04 (GMT+0) Open on Benzinga Other news Nvidia Shares Rise After Earnings Beat in First Report Since Jensen Huang's Exit NVIDIA Chairman Harvey Jones: Board Has No Intention of Restoring Jensen Huang as CEO Slower Retail Sales Drag on Market SEC reportedly investigating Nvidia amid Huang exit A $3 Billion Reason Why Disney Stock Is in Focus Today Google joins the tech outage trend by announcing it’s not having one